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Fatal thrombosis in complex cardiac surgery without deep hypothermic
circulatory arrest in the setting of standard-of-care heparinization:
Status quo and directions for further research
John G. T. Augoustides, MD, FASE, Philadelphia, Pa
Fatal thrombosis in complex cardiac surgery without deephypothermic circulatory arrest was highlighted in a casereport of biventricular assist device placement complicatedby aortic cannula thrombosis and subsequent fatal cerebral
infarction.1 The risk factors identified in this case were aprotinin
exposure and stasis of blood in the aortic cannula after protamine
administration. Despite standard-of-care heparinization, this syn-
drome has persisted, as evidenced by a series of case reports (n  4:
1996-2006).1-4 The purpose of this brief communication is to review
this cumulative case series to guide further investigation. The litera-
ture search was conducted with PubMed (last entry May 31, 2007)
with the following search terms: thrombosis and cardiac surgery;
aprotinin and thrombosis in cardiac surgery; aminocaproic acid and
thrombosis in cardiac surgery; tranexamic acid and thrombosis in
cardiac surgery; and factor VIII and thrombosis in cardiac surgery.
One case report was excluded inasmuch as it was later included as
part of a larger case series.3
As a group, the published case reports of fatal thrombosis in
complex cardiac surgery without deep hypothermic circulatory
arrest can be summarized as follows1-4:
1. The cohort total is 12 patients (7 men; 5 women).
2. The age range is 19 to 69 years.
3. All patients had antifibrinolytic therapy (11 aprotinin; 1
aminocaproic acid).
4. Anticoagulation was with bolus heparin titrated to main-
tain the activated clotting time (ACT) greater than 500
seconds (10 kaolin-based ACT; 1 celite-based ACT; 1
unspecified activator).
5. The type of complex cardiac surgery was as follows: valve
replacement for infective endocarditis in 2 patients; ven-
tricular assist device implantation in 6 patients; heart trans-
plantation in 2 patients; and left ventricular reconstruction
with a mitral valve procedure in 2 patients.
6. In 11 of 12 patients, circulatory collapse resulting from
intravascular thrombosis began within 60 minutes of sep-
aration from cardiopulmonary bypass and protamine ad-
ministration. In the remaining patient, gross thrombus was
seen in the aortic cannula and ascending aorta within 60
minutes of protamine administration.
7. The circulatory collapse was in all cases severe, requiring
reheparinization and return to cardiopulmonary bypass. The
predominant hemodynamic pattern was right ventricular fail-
ure with acute pulmonary hypertension (10/11 cases).
8. The degree of thrombosis in all cases was clinically sig-
nificant and all cardiovascular compartments were at risk:
venous, arterial, capillary, and cardiac chambers. In 3 of
12 patients, the thrombus formation was evident on visual
inspection. In 9 of 12, autopsy demonstrated diffuse mi-
crothrombi.
9. Fibrinolysis with tissue plasminogen activator was used as
emergency rescue therapy in 2 patients. In 1 patient, this
resulted in clinical improvement that allowed transfer to
the intensive care unit. Unfortunately, this patient died
subsequently of massive bleeding.
10. The syndrome has a 100% mortality.
11. In 1 patient, antibodies were detected that activated plate-
lets via Fc-receptor IIa. In 11 of 12 patients, investigation
for coagulation abnormalities was not reported.
This case series is limited by the small sample size and suggests
more questions than answers. Despite these limitations, the following
observations may serve to direct future study of this fatal syndrome:
1. A global case registry would boost sample size and thus
facilitate further analysis.
2. Preoperative hypercoagulable states may participate in the
pathophysiology of the syndrome.
3. In the presence of an antifibrinolytic, standard-of-care
heparinization for complex cardiac surgery in adults does
not protect all patients from serious intraoperative throm-
botic complications.
4. To date, this syndrome has not been reported in associa-
tion with tranexamic acid or recombinant factor VIII.5
5. When a case occurs, the index patient and family should
be investigated for concomitant hypercoagulable states.
Despite the advances in complex cardiac surgery without deep
hypothermic circulatory arrest, there are still patients at risk for
lethal vascular thrombosis. Further investigation is a priority to
delineate the pathogenesis and effective therapy for this rare but
important syndrome.
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Late perforation of right atrium and aortic root after percutaneous
closure of patent foramen ovale
Gaetano Palma, MD, Felice Rosapepe, MD, PhD, Mariano Vicchio, MD, Veronica Russolillo, MD, Sabato Cioffi, MD,
and Carlo Vosa, MD, Naples, Italy
Open heart surgery has been the standard treatment forclosure of atrial septal defects (ASDs) for a half century.In the past decade a variety of devices for transcatheterclosure of ASDs have become available and an increas-
ing number of patients are treated by this alternative method.
Comparative studies have shown a shorter duration of hospital
stay associated with a lower rate of morbidity in patients who under-
went percutaneous occlusion than for those treated with classic sur-
gical procedures.1 Nevertheless, long-term follow-up has demon-
strated excellent outcomes in surgical repair,2 although late incidence
of device failure and emergency interventions must be analyzed.
We report a case of late perforation of the right atrium and the
aortic root by an Amplatzer device (AGA Medical Corp, Golden
Valley, Minn) used to close a patent foramen ovale (PFO), neces-
sitating an emergency surgical procedure.
Clinical Summary
A 28-year-old man with chest pain irradiating to the inferior maxillary
bone and interscapular region was brought to the territorial emergency
department. Thirteen months earlier, because of a history of cerebral
transitory ischemic attacks (TIAs), he had undergone an uncompli-
cated transcatheter PFO closure with an Amplatzer device at another
institution. On clinical examination, the patient was in hemodynam-
ically stable condition, the electrocardiogram showed ST-wave ele-
vation, and the echocardiogram demonstrated an important pericardial
effusion without evidence of cardiac tamponade and revealed the right
disc of the Amplatzer device leaning toward the aortic root. The
transesophageal echocardiogram and computed tomographic scan
confirmed that the left atrial disc of the device had perforated the left
atrium and aortic root. The patient was transferred to our institution
for the necessary emergency surgical procedure.
The operation was performed through a median sternotomy. Car-
diopulmonary bypass was established by ascending aortic and bicaval
cannulation. After antegrade cold cardioplegic arrest, we removed the
23-mm Amplatzer device and the adherent wall of the interatrial
septum (Figures 1 and 2). A transverse aortotomy was performed to
repair the laceration of the aortic root with stitches on pledgets. A
Dacron Sauvage patch was used to repair the interatrial septum. The
right atrium and the aortotomy were closed directly. The patient had
an uncomplicated postoperative recovery and was discharged 6 days
later.
Discussion
Percutaneous transcatheter closure of ASD or PFO has been per-
formed since 1976 as an alternative to conventional surgical repair
with various types of mechanical occluder devices.3 The Am-
platzer septal occluder is a model of such devices and was ap-
proved by the Food and Drug Administration in December 2001.
A good rate of successful closure has been reported. Nevertheless,
cases of late complications necessitating emergency surgical pro-
cedures have been described.4 Our patient had important anatomic
injuries. His hemodynamically stabile condition at the time of
surgical repair was a fortunate situation.
Classic open heart surgery remains the standard of care for ASD
repair with excellent outcomes since 1954, providing low operative
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doi:10.1016/j.jtcvs.2007.06.021 Figure 1. Intraoperative view of the Amplatzer device in the right
atrium.
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